Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

× No keyword cloud information.

307 in total

1. Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine.

Authors: G Bartholini; A Pletscher
Journal: J Pharm Pharmacol Date: 1969-05 Impact factor: 3.765

2. Striatal amines, experimental tremor and the effect of harmaline in the monkey.

Authors: L J Poirier; T L Sourkes; G Bouvier; R Boucher; S Carabin
Journal: Brain Date: 1966-03 Impact factor: 13.501

3. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.

Authors: R Olsson; B E Roos
Journal: Nature Date: 1968-08-03 Impact factor: 49.962

4. Inhibition of glucose oxidase paper tests by reducing metabolites.

Authors: J M Feldman; W N Kelley; H E Lebovitz
Journal: Diabetes Date: 1970-05 Impact factor: 9.461

5. Levodopa and tests for ketonuria.

Authors: W L Dawson
Journal: N Engl J Med Date: 1970-07-30 Impact factor: 91.245

6. Concerning the mechanism of action of L-DOPA in Parkinsonism.

Authors: P Proctor
Journal: Biochem Med Date: 1970-11

7. Stimulation of human-growth-hormone secretion by L-dopa.

Authors: A E Boyd; H E Lebovitz; J B Pfeiffer
Journal: N Engl J Med Date: 1970-12-24 Impact factor: 91.245

8. The role of biogenic amines in the extra-pyramidal system.

Authors: A M Ernst
Journal: Acta Physiol Pharmacol Neerl Date: 1969-06

9. Parkinsonism: onset, progression and mortality.

Authors: M M Hoehn; M D Yahr
Journal: Neurology Date: 1967-05 Impact factor: 9.910

10. Effects of various drugs on 3,4-dihydroxyphenylalanine (DL-DOPA)-induced excitation (agressive behavior) in mice.

Authors: H C Yen; M H Katz; S Krop
Journal: Toxicol Appl Pharmacol Date: 1970-11 Impact factor: 4.219

17 in total

1. Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys.

Authors: E D Levin; R E Bowman; S Wegert; J Vuchetich
Journal: Psychopharmacology (Berl) Date: 1987 Impact factor: 4.530

Review 2. Selegiline: an appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in Parkinson's disease.

Authors: H M Bryson; R J Milne; P Chrisp
Journal: Pharmacoeconomics Date: 1992-08 Impact factor: 4.981

Review 3. Drugs and depression.

Authors: F A Whitlock; L E Evans
Journal: Drugs Date: 1978-01 Impact factor: 9.546

Review 4. Antiparkinsonian drugs: pharmacological and therapeutic aspects.

Authors: D B Calne; J L Reid
Journal: Drugs Date: 1972 Impact factor: 9.546

5. [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors: W Gehlen
Journal: Arch Psychiatr Nervenkr (1970) Date: 1974-04-09

Review 9. Drug-induced psychiatric disorders.

Authors: D A Johnson
Journal: Drugs Date: 1981-07 Impact factor: 9.546

10. Effect of chronic L-DOPA administration of catecholamine metabolism in the rat.

Authors: J Lancaster; P R Sawyer; D M Shepherd; M J Turnbull
Journal: Br J Pharmacol Date: 1973-04 Impact factor: 8.739

Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.